Europe’s pharmaceutical industry wants more clarity on ICH’s modeling guideline
Regulatory NewsJoanne S. Eglovitch
Artificial intelligence/machine learning (AI/ML)EuropeICHModeling and simulationPharmaceuticalsProduct developmentRegulatory Intelligence/PolicyRisk management